Session: Neonatal Hemodynamics and Cardiovascular Medicine 3
068 - HINT: A Novel Scoring Tool for Predicting Severity of Hemodynamic Instability in Neonates.
Saturday, April 26, 2025
2:30pm – 4:45pm HST
Publication Number: 68.5432
Renjini Lalitha, The University of Western Ontario - Schulich School of Medicine & Dentistry, London, ON, Canada; Jennifer Molloy, London Health Sciences Centre, London, ON, Canada; Andrea C. De La Hoz, The University of Western Ontario - Schulich School of Medicine & Dentistry, London, ON, Canada; Shridevi S. Bisanalli, western university, London, ON, Canada; Amr Khalil, LHSC, Western University., London, ON, Canada; Abdulaziz Homedi, National guard, Riyadh, Ar Riyad, Saudi Arabia; Ghada Al Wahbi, LHSC, London, ON, Canada; Catherine Howe, London Health Sciences Centre, London, ON, Canada; Michael Miller, The University of Western Ontario - Schulich School of Medicine & Dentistry, London, ON, Canada; Soume Bhattacharya, Western University, London, ON, Canada
Assistant Professor Western University London, Ontario, Canada
Background: Hemodynamic instability in neonates admitted to Neonatal Intensive Care Unit (NICU) is common and necessitates immediate treatment. The course and severity of hemodynamic instability can be varied. At present, there are no algorithms or tools available to predict episode severity. Objective: This study aimed to develop a scoring system named Hemodynamic Instability in Neonate Tool (acronym HINT) based on hemodynamic and metabolic parameters at the onset of hypotensive episode requiring treatment and analyzed the ability of such a scoring system to predict episode related severity, morbidity, and mortality. Design/Methods: This was a retrospective cohort study at a tertiary care NICU in Southwestern Ontario that included all neonates who needed inotropic support between Jan 1, 2018, to Dec 31, 2022. Data regarding physiological and metabolic parameters in the 6 hours prior to inotropic agent start were collected. Details of the episodes including number of vasoactive agents, doses, vasoactive inotropic score (VIS) and outcomes such as mortality were collected. Univariate and bivariate analyses were performed as appropriate were generated to assess the predictive ability of the tool. Results: 155 neonates were included in the study with a mean (SD) gestational age of 30.03(6.2) weeks. Mean (SD) postnatal age of onset of hypotension was 6.2(12.4) days. 78.1% of neonates were inborn and 63.9% of hypotensive episodes occurred within the first 72 hours of life (Table 1). The HINT scoring system utilized lowest blood pressure (systolic, diastolic, and mean); lowest urine output, highest heart rate, highest capillary refill time, highest base deficit, and maximum oxygen saturation index in the 6 hours prior to initiation of hypotensive agent (Table 2). The scoring system showed a correlation with the VIS score; for every additional point on the severity score scale, VIS increased by 2.05 (95%CI=0.28, 3.82), p=0.023. (Figure 1) The score did not emerge as a good predictor of episode related mortality (AUC 0.57), need of multiple inotrope (AUC 0.63) or days on inotropes. (r= 0.043, p= 0.603).
Conclusion(s): This study designed a novel predictive tool based on physiological and metabolic derangement at onset of hypotensive episode. While higher scores on HINT were associated with higher inotropic support need (VIS) during episode; it did not show reliable accuracy to predict outcomes such as mortality which limits its clinical application. Future studies that incorporate etiology and gestational age within the score could be interesting.
Table1. Baseline demographic and clinical characteristics of cohort
Table 2. Parameters included Hemodynamic Instability in Neonate Tool (HINT)
Figure 1: Higher HINT scores were associated with higher VIS